RIPK3 and cancer: For instance, a study conducted by Liu et al. [17] demonstrated that in several breast cancer cell lines, the knockout of the RIPK1, RIPK3, or MLKL genes in cancer cells markedly reduced their tumorigenicity and appeared to sensitize breast cancer cells to radiotherapy.